Clinical Trial Update: Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating interferon alfa-1b in kidney cancer, including metastatic disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Interferon alfa-1b (interferon alfa-1b)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED